ReviewFrontiers in cell and developmental biology2026
Cardiovascular-kidney-metabolic syndrome: novel molecular mechanism and glucagon-like peptide-1-targeting therapy.
Fengzhao Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.